Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

M.T. Nurmohamed; Y. Bao; J. Signorovitch; A. Trahey; P. Mulani; D.E. Furst

doi:10.1136/rmdopen-2015-000080

Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

M.T. Nurmohamed, Y. Bao, J. Signorovitch, A. Trahey, P. Mulani, D.E. Furst

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	e000080
Journal	RMD Open
Volume	2015
Issue number	1
DOIs	https://doi.org/10.1136/rmdopen-2015-000080
Publication status	Published - 2015

Access to Document

10.1136/rmdopen-2015-000080

Cite this

@article{2908d75c6d074d689629c398764aa58c,

title = "Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis",

author = "M.T. Nurmohamed and Y. Bao and J. Signorovitch and A. Trahey and P. Mulani and D.E. Furst",

year = "2015",

doi = "10.1136/rmdopen-2015-000080",

language = "English",

volume = "2015",

journal = "RMD Open",

issn = "2056-5933",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

AU - Nurmohamed, M.T.

AU - Bao, Y.

AU - Signorovitch, J.

AU - Trahey, A.

AU - Mulani, P.

AU - Furst, D.E.

PY - 2015

Y1 - 2015

U2 - 10.1136/rmdopen-2015-000080

DO - 10.1136/rmdopen-2015-000080

M3 - Article

C2 - 26535138

VL - 2015

JO - RMD Open

JF - RMD Open

SN - 2056-5933

IS - 1

M1 - e000080

ER -